The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...

GILL Nibbs was a “vibrant” woman who lived a seemingly perfectly healthy lifestyle.  “She walked everywhere, didn’t smoke or ...

The charity said that a growing and ageing population is driving the number of cancer cases up, as well as a gradual increase ...

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

Researchers at the University of Washington analyzed data on the five and ten-year survival rates for 4,355 people diagnosed ...

Kolkata: Cancer care is set to take a leap forward across multiple city hospitals that are enhancing oncology units even as ...

Cancer is the leading cause of death worldwide, responsible for nearly 10 million deaths in 2020, or about one in six deaths, ...

Data presented at the ASCO Gastrointestinal Cancers Symposium showed the regimen may be a new option, but it comes with more treatment and financial toxicity.

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...

pulse and heart rate, and metabolism. However, terminology like thyroid cancer and thyroid nodules are becoming more popular these days, so it's important to grasp how they relate to one another.” ...

Thyroid cancer is a disease in which malignant (cancer) cells form in the tissues of the thyroid gland. In 2020, there were ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...